Previous 10 | Next 10 |
home / stock / prn:cc / prn:cc news
TORONTO, Dec. 27, 2023 (GLOBE NEWSWIRE) -- Profound Medical Corp. (TSX:PRN; NASDAQ:PROF) (“ Profound ” or the “ Company ”) today announced the pricing of its previously announced underwritten public offering (the “ Offering ”) of 2,666,667 com...
2023-12-27 16:25:29 ET More on Profound Medical Profound Medical Corp. (PROF) Q3 2023 Earnings Call Transcript Stifel starts coverage of Profound Medical with hold rating Seeking Alpha’s Quant Rating on Profound Medical Historical earnings data for Pro...
TORONTO, Dec. 27, 2023 (GLOBE NEWSWIRE) -- Profound Medical Corp. (TSX:PRN; NASDAQ:PROF) (“ Profound ” or the “ Company ”) is pleased to announce the commencement of an underwritten public offering in the United States of common shares (the “ Common Sh...
2023-12-01 15:27:39 ET More on Profound Medical Profound Medical Corp. (PROF) Q3 2023 Earnings Call Transcript Profound Medical receives FDA 510(k) clearance for TULSA-PRO Thermal Boost Profound Medical gains as investment bank Raymond James raises rating to Strong B...
TORONTO, Nov. 08, 2023 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue, to...
2023-11-04 11:45:25 ET Profound Medical Corp. (PROF) Q3 2023 Earnings Conference Call November 02, 2023 16:30 P.M. ET Company Participants Stephen Kilmer - IR Arun Menawat - Chairman and CEO Rashed Dewan - CFO Conference Call Participants Rahul Saruga...
TORONTO, Nov. 03, 2023 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue, an...
2023-11-02 17:07:40 ET Profound Medical press release ( NASDAQ: PROF ): Q3 GAAP EPS of -$0.26 beats by $0.07 . Revenue of $1.7M (-16.3% Y/Y) misses by $0.4M . As at September 30, 2023, Profound had cash of approximately $33.6 million. For further details ...
TORONTO, Nov. 02, 2023 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue, to...
Baytex Energy Corp. (BTE:CA) is expected to report $0.23 for Q3 2023 Logistec Corporation Class A Common Shares (LGT.A:CA) is expected to report for Q1 2024 ARC Resources Ltd. (ARX:CA) is expected to report $0.48 for Q3 2023 Lightspeed Commerce Inc. Subordinate Voting Shares (LSPD:CA)...
News, Short Squeeze, Breakout and More Instantly...
Profound Medical Corp. Company Name:
PRN:CC Stock Symbol:
TSXC Market:
Profound Medical Corp. Website:
TORONTO, July 11, 2024 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue, today ...
TORONTO, May 15, 2024 (GLOBE NEWSWIRE) -- Profound Medical Corp. (TSX: PRN; NASDAQ: PROF) (“Profound” or the “Company”) is pleased to announce the voting results from its Annual General Meeting of Shareholders that was held today (the “Meeting”). A total ...
PROFOUND MEDICAL ANNUAL GENERAL MEETING OF SHAREHOLDERS VOTING RESULTS Canada NewsWire TORONTO , May 15, 2024 /CNW/ - Profound Medical Corp. (TSX: PRN) (NASDAQ: PROF) ("Profound" or the "Company") is pleased to announce the voting results from its Annual General ...